BPC-157
One of the most researched regenerative peptides. BPC-157 (Body Protection Compound-157) is a 15 amino acid peptide known for its role in supporting tissue repair and recovery.
Compound Profile
Pharmaceutical Data Sheet
Mechanism of Action
How BPC-157 Works
BPC-157 exerts its regenerative effects through simultaneous engagement of multiple biological signaling pathways. Unlike single-target compounds, its therapeutic breadth stems from coordinated activation of vascular growth, nitric oxide production, and growth factor upregulation — enabling repair across tissue types.
- Upregulates VEGFR2 surface expression
- Stimulates endothelial proliferation
- Drives angiogenesis at injury sites
- Accelerates capillary ingrowth into damaged tissue
- Activates eNOS via Akt phosphorylation
- Regulates vascular tone and perfusion
- Reduces ischemic injury in GI mucosa
- Coordinates with VEGF for vascular remodeling
- Upregulates EGF, FGF, and PDGF expression
- Stimulates fibroblast and myocyte proliferation
- Enhances collagen type I and III synthesis
- Promotes satellite cell activation in muscle
BPC-157 directly upregulates VEGFR2 expression and activates downstream Akt phosphorylation, which in turn drives eNOS activity. This cascade triggers localized nitric oxide production and angiogenesis — the formation of new capillaries essential for tissue oxygenation and repair.
J Mol Med (2017): BPC-157 upregulates VEGFR2 expression and activates Akt/eNOS cascade in endothelial cells.
Preclinical Findings
Research Models
Clinical Data
7/12 Patients Achieved Pain Relief >6 Months
A 2025 systematic review of human BPC-157 studies reported that in a knee osteoarthritis cohort, 7 out of 12 patients achieved sustained pain relief lasting more than 6 months following administration.
J Clin Rheumatol (2025): Systematic review of BPC-157 in musculoskeletal disorders.
Human clinical case series, n=12
Research Outcomes
Key Research Success Metrics
Safety Profile
Research Safety Notes
- No LD50 established in any animal model — exceptional safety ceiling
- No significant adverse events reported across 200+ preclinical studies
- No carcinogenic, mutagenic, or teratogenic signals observed
- Well-tolerated across IP, IV, oral, and subcutaneous routes of administration
- No receptor downregulation or desensitization with chronic administration
The majority of BPC-157 evidence derives from preclinical (animal) studies. Human clinical data is limited to case series and early-phase work. This compound is for research use only.
About BPC-157
One of the most researched regenerative peptides. BPC-157 (Body Protection Compound-157) is a 15 amino acid peptide known for its role in supporting tissue repair and recovery.
All EVO Labs Research compounds are manufactured to research-grade standards and independently tested by Janoshik Analytical (Prague, est. 2013). The Certificate of Analysis for this compound includes full HPLC chromatography data, mass spectrometry confirmation, net purity percentage, and net content verification.
Research Use Only
This product is strictly for in vitro research and laboratory use only. Not for human or veterinary consumption. By purchasing, you confirm use in a controlled research setting.
